Ocular Therapeutix Aktie
8,20
EUR
-0,05
EUR
-0,61
%
9,42
USD
+0,01
USD
+0,11
%
Ocular Therapeutix jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Ocular Therapeutix Aktie Analyse
| 21.05.19 | Ocular Therapeutix Buy | H.C. Wainwright & Co. | |
| 21.05.19 | Ocular Therapeutix Market Perform | Cowen and Company, LLC | |
| 03.12.18 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 26.07.17 | Ocular Therapeutix Buy | H.C. Wainwright & Co. | |
| 12.07.17 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 10.02.17 | Ocular Therapeutix Overweight | Cantor Fitzgerald | |
| 15.11.16 | Ocular Therapeutix Outperform | RBC Capital Markets | |
| 08.04.15 | Ocular Therapeutix Outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 11.03.15 | Ocular Therapeutix Outperform | Oppenheimer & Co. Inc. | |
| 11.03.15 | Ocular Therapeutix Outperform | RBC Capital Markets | |
| 30.01.15 | Ocular Therapeutix Outperform | Oppenheimer & Co. Inc. | |
Werbung
Werbung